Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Panagiotis Kougias

Vascular Surgery Houston, TX Medical Doctor

NPI 1801976063 CMS profile 172302

2002 Holcombe Blvd, Houston, TX 77030

Open in the dashboard

General payments

$17,433

74 records reported · program years 2019–2025

Research payments

$15,224

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$7,779 paid to institutions, not to them · program year 2019

Through program year 2025, Panagiotis Kougias of Houston, TX is reported in the CMS Open Payments database as having received $17,433 across 74 general payments and $15,224 in research payments paid to them. Separately, studies naming them as principal investigator received $7,779 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $279 10
2024 General $183 3
2023 General $172 3
2023 Research $2,982 3
2022 General $182 6
2022 Research $1,952 3
2021 General $348 8
2021 Research $5,181 4
2020 General $4,940 21
2020 Research $5,109 3
2019 General $11,330 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Panagiotis Kougias
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Panagiotis Kougias were reported at $279. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Panagiotis Kougias Vascular Surgery median Middle half National median
2019 $11,330 $796 $226–$2,363 $163
2020 $4,940 $348 $118–$1,110 $114
2021 $348 $471 $158–$1,421 $132
2022 $182 $725 $222–$2,183 $149
2023 $172 $836 $257–$2,440 $160
2024 $183 $909 $252–$2,619 $164
2025 $279 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $11,645 9 payments
  2. W. L. Gore & Associates, Inc. $2,499 13 payments
  3. Cook Medical LLC $2,267 28 payments
  4. Medtronic Vascular, Inc. $228 2 payments
  5. Bard Peripheral Vascular, Inc. $144 1 payment
  6. Becton, Dickinson and Company $115 1 payment
  7. Inari Medical, Inc. $106 3 payments
  8. Ethicon US, LLC $62 2 payments
  9. Cordis US Corp. $61 2 payments
  10. Smith+Nephew, Inc. $60 2 payments
  11. Other $247 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $8,000 4 payments
  2. Travel and Lodging $5,067 10 payments
  3. Food and Beverage $2,867 59 payments
  4. Consulting Fee $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Cook Medical AFEN $5,368 6 payments
  2. Cook Medical Advanced Tech $2,500 1 payment
  3. Cook Medical Zenith $2,454 4 payments
  4. Cook Medical AAA $1,519 6 payments
  5. Cook Medical Aortic Intervention $1,109 5 payments
  6. TAG Thoracic Endoprosthesis $1,083 2 payments
  7. Product in Development $864 5 payments
  8. EXCLUDER AAA Endoprosthesis $381 3 payments
  9. Cook Medical Custom Made Device $238 4 payments
  10. Cook Medical Lead Management $231 1 payment
  11. Other $1,869 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $15,224 13 payments

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$24,779

Medicare's payments for the services billed

Medicare patients

95

Average age 74

Services billed

237

53 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 74%
Arthritis 61%
Chronic kidney disease 60%
Heart failure 54%
Ischemic heart disease 51%
Depression 31%
Alzheimer's or dementia 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

87 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record